Zhenglei Xu Selected Research

2,7- dioxo- 2,7- dihydro- 3H- naphtho(1,2,3- de)quinoline- 1- carboxylate

11/2019

NQDI-1 protects against acinar cell necrosis in three experimental mouse models of acute pancreatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhenglei Xu Research Topics

Disease

5	Stomach Neoplasms (Stomach Cancer) 01/2023 - 12/2013
5	Neoplasms (Cancer) 12/2022 - 07/2015
4	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022 - 01/2020
3	Hypoxia (Hypoxemia) 09/2020 - 12/2015
2	Ulcerative Colitis 01/2022 - 12/2015
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021 - 01/2020
2	Pancreatitis 11/2019 - 04/2019
2	Carcinogenesis 10/2017 - 07/2015
1	Inflammation (Inflammations) 01/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022
1	Myocardial Infarction 09/2020
1	Necrosis 11/2019
1	Acute Necrotizing Pancreatitis 11/2019
1	Abdominal Obesity 04/2019
1	Hypertriglyceridemic Waist 04/2019
1	Tuberculous Peritonitis 12/2018
1	Adenocarcinoma 03/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Neoplasm Metastasis (Metastasis) 10/2017
1	Colitis 12/2015
1	Colorectal Neoplasms (Colorectal Cancer) 07/2015
1	Colonic Neoplasms (Colon Cancer) 05/2015
1	Gout 01/2015
1	Hemorrhage 01/2015
1	Peptic Ulcer Hemorrhage 01/2015

Drug/Important Bio-Agent (IBA)

7	Long Noncoding RNAIBA 12/2022 - 01/2018
7	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 11/2019 - 07/2015
2	GraphiteIBA 01/2021 - 01/2021
1	3,3',4,5'-tetrahydroxystilbeneIBA 01/2022
1	Antisense RNA (Anti-Sense RNA)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	CytokinesIBA 12/2021
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 01/2021
1	Carcinoembryonic AntigenIBA 01/2021
1	CarbonIBA 01/2021
1	CarbohydratesIBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2019
1	2,7- dioxo- 2,7- dihydro- 3H- naphtho(1,2,3- de)quinoline- 1- carboxylateIBA 11/2019
1	Indicators and Reagents (Reagents)IBA 04/2019
1	Triglycerides (Triacylglycerol)IBA 04/2019
1	tributyl phosphate (TBP)IBA 12/2018
1	ErbB Receptors (EGF Receptor)IBA 03/2018
1	Trastuzumab (Herceptin)FDA Link 03/2018
1	LigandsIBA 10/2017
1	imperatorinIBA 05/2017
1	Therapeutic UsesIBA 12/2015
1	InterleukinsIBA 12/2015
1	Interleukin-17 (Interleukin 17)IBA 12/2015
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 12/2015
1	Interleukin-6 (Interleukin 6)IBA 12/2015
1	Interleukin-10 (Interleukin 10)IBA 12/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2015
1	3-Phosphoinositide-Dependent Protein KinasesIBA 07/2015
1	Messenger RNA (mRNA)IBA 07/2015
1	Cyclin D1IBA 07/2015
1	Fluorouracil (Carac)FDA LinkGeneric 05/2015
1	Sirtuin 1IBA 05/2015
1	Celecoxib (Celebrex)FDA Link 01/2015
1	Methylprednisolone Hemisuccinate (A-MethaPred)FDA LinkGeneric 01/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2013

Therapy/Procedure

3	Therapeutics 12/2022 - 01/2015
2	Drug Therapy (Chemotherapy) 01/2023 - 03/2018
2	Ligation 09/2020 - 01/2015
1	Immunotherapy 01/2022
1	Central Venous Catheters 12/2018